News

Cornea and Anterior Segment Services ... A complete air fill was maintained in all cases at the end of the surgery. Peripheral iridotomy was made to prevent pupillary block. Postoperatively the ...
Two University of Iowa professors are heading a research team that is exploring ways to prevent or reduce vision loss from a ...
Pentacam and corneal topography were more sensitive to tear film abnormalities when measuring the curvature of the cornea in ...
Scientists present current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec. AAN Evidence in Focus articles highlight the strength of the current ...
Duchenne muscular dystrophy (DMD), recognised by the World Health Organization (WHO) as a rare disease, is the most common form of childhood muscular dystrophy. It is a progressive genetic ...
"For nearly a decade, Sarepta has been a leader in advancing the treatment of Duchenne muscular dystrophy through innovative treatment options. With the approval of ELEVIDYS in Japan, children who ...
To help neurologists, clinicians and families understand the current evidence for a new gene therapy for Duchenne muscular dystrophy called delandistrogene moxeparvovec, the American Academy of ...
Correction of astigmatism during cataract surgery: on axis corneal incision, peripheral corneal relaxing incisions and toric IOL are options to correct corneal astigmatism during cataract surgery.
A disparity in UK access to a medicine for Duchenne muscular dystrophy (DMD) has been addressed, after Scotland gave a green light to use of PTC Therapeutics' Translarna for the first time.
The early techniques involved removing the entire opaque lens in one piece using an incision that went halfway around the circumference of the cornea. It was critical that the lens remained intact ...
Its key assets include product candidates for Duchenne muscular dystrophy (DMD), Friedreich’s ataxia, and BAG3 mediated dilated cardiomyopathy, among others. Once combined, the next step is to ...